Answers are grounded in this paper and cite their sources.
BACKGROUND: Clinical Academic Group (CAG) is a new organization of treatment bringing together clinical services, research, education, and training to provide evidence-based care. We aimed, for the first time, to investigate whether specialized and centralized outpatient treatment (CAG Bipolar) versus decentralized community-based treatment improves patient outcomes and satisfaction with care in patients with progressed bipolar disorder. METHODS: A pragmatic randomized controlled trial was undertaken with individual randomization to 1) specialized and centralized outpatient treatment in CAG Bipolar or 2) generalized and decentralized community-based outpatient treatment. The 12-month outcomes were 1) cumulated number and duration of psychiatric hospitalizations, and 2) psychotropic medication, coercion, self-rated depressive and manic symptoms, quality of life, perceived stress, and satisfaction with care. Lithium (RR: 1.19 (95% CI: 1.05-1.33) and antipsychotics (RR: 1.09 (95% CI: 1.01-1.17), specifically quetiapine (RR: 1.17 (95% CI: 1.03-1.30), were prescribed more in the CAG Bipolar group, and CAG Bipolar patients were overall more satisfied with care including the skills of the professionals, information and the efficacy of the service. There was no difference in coercion, self-rated depressive or manic symptoms, quality of life or perceived stress. CONCLUSIONS: Specialized and centralized outpatient treatment for progressed bipolar disorder does not result in improvement in robust outcome measures such as hospitalization and coercion, but in the use of psychotropic medication concordant with international guidelines, and increased satisfaction with care.
No takes yet. Share an insight, caveat, or question.
Kessing et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: